Rexnord Corporation (RXN) Stock Competitors & Peer Comparison
See (RXN) competitors and their performances in Stock Market.
Peer Comparison Table: Regulated Water Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RXN | $64.95 | +0.90% | 11.4B | N/A | N/A | +0.54% |
| AWK | $124.47 | +1.82% | 24.3B | 22.04 | $5.65 | +2.68% |
| SBS | $5.35 | -2.55% | 18.2B | 10.67 | $0.50 | +4.00% |
| WTRG | $37.36 | +1.66% | 10.6B | 19.07 | $1.96 | +3.64% |
| AWR | $78.37 | +1.75% | 3.1B | 22.85 | $3.43 | +2.57% |
| CWT | $45.82 | +1.28% | 2.7B | 22.93 | $2.00 | +2.76% |
| HTO | $57.43 | +1.56% | 2B | 19.67 | $2.92 | +2.99% |
| WTTR | $18.01 | -6.25% | 1.9B | 85.79 | $0.21 | +1.56% |
| SJW | $54.86 | -0.67% | 1.9B | 18.29 | $3.00 | +1.60% |
| CDZIP | $22.45 | -1.35% | 1.9B | -26.91 | -$0.83 | N/A |
Stock Comparison
RXN vs AWK Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWK has a market cap of 24.3B. Regarding current trading prices, RXN is priced at $64.95, while AWK trades at $124.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWK's P/E ratio is 22.04. In terms of profitability, RXN's ROE is +0.13%, compared to AWK's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to AWK. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check AWK's competition here
RXN vs SBS Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SBS has a market cap of 18.2B. Regarding current trading prices, RXN is priced at $64.95, while SBS trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SBS's P/E ratio is 10.67. In terms of profitability, RXN's ROE is +0.13%, compared to SBS's ROE of +0.20%. Regarding short-term risk, RXN is less volatile compared to SBS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SBS's competition here
RXN vs WTRG Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRG has a market cap of 10.6B. Regarding current trading prices, RXN is priced at $64.95, while WTRG trades at $37.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRG's P/E ratio is 19.07. In terms of profitability, RXN's ROE is +0.13%, compared to WTRG's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to WTRG. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRG's competition here
RXN vs AWR Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, AWR has a market cap of 3.1B. Regarding current trading prices, RXN is priced at $64.95, while AWR trades at $78.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas AWR's P/E ratio is 22.85. In terms of profitability, RXN's ROE is +0.13%, compared to AWR's ROE of +0.13%. Regarding short-term risk, RXN is less volatile compared to AWR. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check AWR's competition here
RXN vs CWT Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWT has a market cap of 2.7B. Regarding current trading prices, RXN is priced at $64.95, while CWT trades at $45.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWT's P/E ratio is 22.93. In terms of profitability, RXN's ROE is +0.13%, compared to CWT's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to CWT. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CWT's competition here
RXN vs HTO Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, HTO has a market cap of 2B. Regarding current trading prices, RXN is priced at $64.95, while HTO trades at $57.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas HTO's P/E ratio is 19.67. In terms of profitability, RXN's ROE is +0.13%, compared to HTO's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to HTO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check HTO's competition here
RXN vs WTTR Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTTR has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while WTTR trades at $18.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTTR's P/E ratio is 85.79. In terms of profitability, RXN's ROE is +0.13%, compared to WTTR's ROE of +0.03%. Regarding short-term risk, RXN is less volatile compared to WTTR. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTTR's competition here
RXN vs SJW Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, SJW has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while SJW trades at $54.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas SJW's P/E ratio is 18.29. In terms of profitability, RXN's ROE is +0.13%, compared to SJW's ROE of +0.07%. Regarding short-term risk, RXN is less volatile compared to SJW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check SJW's competition here
RXN vs CDZIP Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZIP has a market cap of 1.9B. Regarding current trading prices, RXN is priced at $64.95, while CDZIP trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZIP's P/E ratio is -26.91. In terms of profitability, RXN's ROE is +0.13%, compared to CDZIP's ROE of -1.30%. Regarding short-term risk, RXN is less volatile compared to CDZIP. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZIP's competition here
RXN vs MSEX Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, MSEX has a market cap of 994M. Regarding current trading prices, RXN is priced at $64.95, while MSEX trades at $53.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas MSEX's P/E ratio is 22.24. In terms of profitability, RXN's ROE is +0.13%, compared to MSEX's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to MSEX. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check MSEX's competition here
RXN vs YORW Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, YORW has a market cap of 490.8M. Regarding current trading prices, RXN is priced at $64.95, while YORW trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas YORW's P/E ratio is 20.60. In terms of profitability, RXN's ROE is +0.13%, compared to YORW's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to YORW. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check YORW's competition here
RXN vs CWCO Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CWCO has a market cap of 478.7M. Regarding current trading prices, RXN is priced at $64.95, while CWCO trades at $29.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CWCO's P/E ratio is 27.45. In terms of profitability, RXN's ROE is +0.13%, compared to CWCO's ROE of +0.08%. Regarding short-term risk, RXN is more volatile compared to CWCO. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check CWCO's competition here
RXN vs CDZI Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, CDZI has a market cap of 348.1M. Regarding current trading prices, RXN is priced at $64.95, while CDZI trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas CDZI's P/E ratio is -9.00. In terms of profitability, RXN's ROE is +0.13%, compared to CDZI's ROE of -1.30%. Regarding short-term risk, RXN is less volatile compared to CDZI. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check CDZI's competition here
RXN vs ARTNA Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, ARTNA has a market cap of 340.3M. Regarding current trading prices, RXN is priced at $64.95, while ARTNA trades at $32.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas ARTNA's P/E ratio is 14.65. In terms of profitability, RXN's ROE is +0.13%, compared to ARTNA's ROE of +0.09%. Regarding short-term risk, RXN is less volatile compared to ARTNA. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check ARTNA's competition here
RXN vs VWTR Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, VWTR has a market cap of 288.2M. Regarding current trading prices, RXN is priced at $64.95, while VWTR trades at $15.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas VWTR's P/E ratio is 9.29. In terms of profitability, RXN's ROE is +0.13%, compared to VWTR's ROE of +0.17%. Regarding short-term risk, RXN is more volatile compared to VWTR. This indicates potentially higher risk in terms of short-term price fluctuations for RXN.Check VWTR's competition here
RXN vs PCYO Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, PCYO has a market cap of 252.6M. Regarding current trading prices, RXN is priced at $64.95, while PCYO trades at $10.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas PCYO's P/E ratio is 18.39. In terms of profitability, RXN's ROE is +0.13%, compared to PCYO's ROE of +0.10%. Regarding short-term risk, RXN is less volatile compared to PCYO. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check PCYO's competition here
RXN vs GWRS Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, GWRS has a market cap of 208.2M. Regarding current trading prices, RXN is priced at $64.95, while GWRS trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas GWRS's P/E ratio is 90.50. In terms of profitability, RXN's ROE is +0.13%, compared to GWRS's ROE of +0.02%. Regarding short-term risk, RXN is less volatile compared to GWRS. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check GWRS's competition here
RXN vs WTRU Comparison June 2026
RXN plays a significant role within the Utilities sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RXN stands at 11.4B. In comparison, WTRU has a market cap of 0. Regarding current trading prices, RXN is priced at $64.95, while WTRU trades at $53.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RXN currently has a P/E ratio of N/A, whereas WTRU's P/E ratio is 60.58. In terms of profitability, RXN's ROE is +0.13%, compared to WTRU's ROE of +0.08%. Regarding short-term risk, RXN is less volatile compared to WTRU. This indicates potentially lower risk in terms of short-term price fluctuations for RXN.Check WTRU's competition here